Abstract
BackgroundSWITCH-RA is a global observational study evaluating the effectiveness of switching to an alternative TNFi or to rituximab (RTX) following initial TNFi failure in patients with RA. This subanalysis assessed...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
